Novel Tumor-Targeting Nanoparticles for Cancer Treatment-A Review

Int J Mol Sci. 2022 May 8;23(9):5253. doi: 10.3390/ijms23095253.

Abstract

Being one of the leading causes of death and disability worldwide, cancer represents an ongoing interdisciplinary challenge for the scientific community. As currently used treatments may face limitations in terms of both efficiency and adverse effects, continuous research has been directed towards overcoming existing challenges and finding safer specific alternatives. In particular, increasing interest has been gathered around integrating nanotechnology in cancer management and subsequentially developing various tumor-targeting nanoparticles for cancer applications. In this respect, the present paper briefly describes the most used cancer treatments in clinical practice to set a reference framework for recent research findings, further focusing on the novel developments in the field. More specifically, this review elaborates on the top recent studies concerning various nanomaterials (i.e., carbon-based, metal-based, liposomes, cubosomes, lipid-based, polymer-based, micelles, virus-based, exosomes, and cell membrane-coated nanomaterials) that show promising potential in different cancer applications.

Keywords: cancer management; cancer treatment; combined cancer therapies; controlled drug delivery; nanomedicines; novel nanocarriers; theranostics; tumor-targeting nanoparticles.

Publication types

  • Review

MeSH terms

  • Drug Carriers / therapeutic use
  • Drug Delivery Systems / methods
  • Humans
  • Liposomes / therapeutic use
  • Micelles
  • Nanoparticles* / therapeutic use
  • Neoplasms* / drug therapy

Substances

  • Drug Carriers
  • Liposomes
  • Micelles

Grants and funding

This research received no external funding.